CTRI/2021/07/034814尚未招募未知
ROLE OF PDL1 IN SEROUS CARCINOMA OVARY AND ITS ASSOCIATION WITH TUMOUR INFILTRATING LYMPHOCYTES (TILs)
Dr Anubhuti Chaturvedi0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Cases diagnosed as Serous Ovarian Cancer on Histopathology
排除标准
- •Other Histological types of Epithelial Ovarian Carcinomas- Endometrioid, Clear cell, and Mucinous type
- •Other types of Ovarian Carcinomas- Germ Cell, Sex cord-Stromal
研究者
相似试验
Unknown
不适用
PD-L1 Expression in Advanced OsteosarcomaProgressionSurvivalNCT03582527Peking University People's Hospital50
已完成
不适用
The Role of Programmed Death Ligand -1 (Pdl-1) in Lung CancerLung CancerNCT05082636Assiut University90
已完成
1 期
A Trial to Evaluate Safety and Tolerability of SHR-1316 in Cancer PatientsAdvanced Solid TumorsNCT03133247Atridia Pty Ltd.37
已完成
Unknown
Clinicopathologic relationships of tumor markers and tumor microenvironment in bladder cancer treated with transurethral resection of bladder tumorKCT0008858GangNeung Asan Hospital350
已完成
不适用
PDL1 in Ovarian High Grade Serous CarcinomaOvarian CancerNCT04507191Port Said University hospital54